Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Jul 04, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹16.6894+0.63% 1 day change | 14.88% p.a. | ₹221 Cr |
Expense ratio | 2.35% as on May 31, 2025 |
Exit load | 0.5% Exit load of 0.50%, if redeemed within 3 months.! |
AUM (Fund size) | ₹221 Cr |
Lock-in Period | Nil |
Age | 3 yrs 9 m since Oct 18, 2021 |
Benchmark | NIFTY Healthcare TRI. |
Min. investment | This scheme is currently not buyable |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Large Cap 30.79%
Mid Cap 35.32%
Small Cap 33.6%
Other Cap 0%
Healthcare 93.85000000000002%
Chemicals 3.6399999999999997%
Services 1.29%
Diversified 0.93%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Bifurcation by Instrument is not available for this fund
Others 0.29%
Fund name | ETM Rank | AUM | Fund age | Expense ratio |
---|---|---|---|---|
ITI Pharma and Healthcare Fund | N.A. | 221 Cr | 3 yrs 9 m | 2.35% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 5,295 Cr | 7 yrs | 1.06% |
SBI Healthcare Opportunities Fund | N.A. | 3,671 Cr | 12 yrs 6 m | 0.9% |
DSP Healthcare Fund | N.A. | 2,961 Cr | 6 yrs 8 m | 0.62% |
Tata India Pharma & HealthCare Fund | N.A. | 1,232 Cr | 9 yrs 7 m | 0.63% |
Mirae Asset Healthcare Fund | N.A. | 2,691 Cr | 7 yrs 1 m | 0.5% |
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
ITI Pharma and Healthcare Fund | 3.83% | -3.7% | 14.17% | 24.24% | N.A. | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 3.43% | 1.2% | 20.63% | 31.26% | 26.07% | 15.86% |
SBI Healthcare Opportunities Fund | 4.0% | 0.59% | 20.95% | 31.0% | 26.13% | 13.11% |
DSP Healthcare Fund | 4.0% | -4.21% | 15.5% | 28.25% | 25.24% | 15.82% |
Tata India Pharma & HealthCare Fund | 3.9% | -1.8% | 14.52% | 27.21% | 24.23% | 13.52% |
Mirae Asset Healthcare Fund | 4.41% | -0.53% | 17.02% | 26.08% | 24.35% | 15.79% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
ITI Pharma and Healthcare Fund | 15.42 | 0.95 | 1.07 | 1.49 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.37 | 0.94 | 1.44 | 2.04 |
SBI Healthcare Opportunities Fund | 13.71 | 0.84 | 1.58 | 2.27 |
DSP Healthcare Fund | 14.68 | 0.85 | 1.35 | 2.22 |
Tata India Pharma & HealthCare Fund | 15.95 | 0.99 | 1.2 | 1.83 |
Mirae Asset Healthcare Fund | 16.24 | 1.0 | 1.11 | 1.76 |
Alpha | -2.12 vs. 6.7 Underperformed at beating benchmark |
Sharpe | 1.07 vs. 4.61 Poor risk-adjusted returns |
Beta | 0.95 vs. 0.79 More sensitive to market's ups & downs |
Standard deviation | 15.42 vs. 9.0 More volatile performance |
Fund AUM | 221 Cr as on May 31, 2025 |
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
No. of schemes | 0 view all schemes |
Total AUM | 9,293 Cr as on Mar 31, 2025 |
Address | ITI Asset Mangement Limited, ITI House, Building no. 36, Dr. R. K. Shirodkar Marg, Parel, Mumbai, 400012 |
mfassist@itiorg.com | |
Phone | 022-66214999 |
The current Net Asset Value (NAV) of the ITI Pharma and Healthcare Fund - Direct Growth plan is approximately ₹16.6894 as of Jul 04, 2025.
The ITI Pharma and Healthcare Fund is a 3 yrs 9 m old fund and has delivered average annual returns of 14.88% since inception.
1-Year | 3-Year | Since Inception |
---|---|---|
14.17% | 24.24% | 14.88% |
The ITI Pharma and Healthcare Fund - Direct Growth has an expense ratio of 2.35%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.
The ITI Pharma and Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 221 Cr as on May 31, 2025.
The ITI Pharma and Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Sun Pharmaceutical Industries Ltd. | 15.18% |
Divi's Laboratories Ltd. | 9.12% |
Max Healthcare Institute Ltd. | 5.42% |
Lupin Ltd. | 5.4% |
Apollo Hospitals Enterprise Ltd. | 5.19% |
Cohance Lifesciences Ltd. | 4.84% |
Aurobindo Pharma Ltd. | 3.93% |
Torrent Pharmaceuticals Ltd. | 3.91% |
Aster DM Healthcare Ltd. | 3.15% |
Mankind Pharma Ltd. | 3.04% |
The ITI Pharma and Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 93.85000000000002% |
Chemicals | 3.6399999999999997% |
Services | 1.29% |
Diversified | 0.93% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
ITI Pharma and Healthcare Fund Regular - Growth is the regular plan of the fund. For this plan of you pay 2.35% as annual charges. On the other hand if you go for the direct plan available on ET Money, you pay 0.47%. That's 1.8800000000000001% less.
Regular plans charge more because when you buy them, the fund pays commission to the agent. This is an additional expense for the fund and to cover this expense, the fund takes a bigger share from the returns generated by your investments.
So, the lower annual cost of the direct plan means you will earn 1.8800000000000001% if you opt for direct plan of ITI Pharma and Healthcare Fund
Redeeming your investments in ITI Pharma and Healthcare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in ITI Pharma and Healthcare Fund from anywhere else, you can go to the fund house website and put a request through it.